• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弱精子症:细胞和分子影响因素及治疗策略

Asthenozoospermia: Cellular and molecular contributing factors and treatment strategies.

作者信息

Shahrokhi Seyedeh Zahra, Salehi Peyman, Alyasin Atieh, Taghiyar Sana, Deemeh Mohammad Reza

机构信息

Department of Laboratory Medicine, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Infertility Center, Shahid Beheshti Hospital, Isfahan, Iran.

出版信息

Andrologia. 2020 Mar;52(2):e13463. doi: 10.1111/and.13463. Epub 2019 Nov 3.

DOI:10.1111/and.13463
PMID:31680293
Abstract

Semen sample with poor sperm motility, which called asthenozoospermia, is considered as one of the main factors contributing to male infertility. Recognition of the cellular and molecular pathways contributing to sperm motility reduction may lead to applying novel treatment strategies for overcoming low sperm motility in asthenozoospermia individuals. In this review, we intend to discuss the main causes of sperm motility reduction in asthenozoospermia and some treatment strategies used to overcome low sperm motility.

摘要

精子活力差的精液样本,即所谓的弱精子症,被认为是导致男性不育的主要因素之一。认识到导致精子活力降低的细胞和分子途径,可能会带来新的治疗策略,以克服弱精子症患者精子活力低的问题。在这篇综述中,我们打算讨论弱精子症中精子活力降低的主要原因以及一些用于克服精子活力低的治疗策略。

相似文献

1
Asthenozoospermia: Cellular and molecular contributing factors and treatment strategies.弱精子症:细胞和分子影响因素及治疗策略
Andrologia. 2020 Mar;52(2):e13463. doi: 10.1111/and.13463. Epub 2019 Nov 3.
2
Electron microscopy in the investigation of asthenozoospermia.电子显微镜在弱精子症研究中的应用
Br J Biomed Sci. 2010;67(2):92-100. doi: 10.1080/09674845.2010.11730302.
3
Metabolic Dysregulation and Sperm Motility in Male Infertility.代谢失调与男性不育症精子活力
Adv Exp Med Biol. 2022;1358:257-273. doi: 10.1007/978-3-030-89340-8_12.
4
Absolute asthenozoospermia and ICSI: what are the options?绝对型弱精症与卵胞浆内单精子注射:有哪些选择?
Hum Reprod Update. 2011 Sep-Oct;17(5):684-92. doi: 10.1093/humupd/dmr018. Epub 2011 Aug 3.
5
[Sperm DNA oxidative damage in patients with idiopathic asthenozoospermia].[特发性弱精子症患者的精子DNA氧化损伤]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;37(1):100-5. doi: 10.3969/j.issn.1672-7347.2012.01.018.
6
Proteomics analysis of asthenozoospermia and identification of glucose-6-phosphate isomerase as an important enzyme for sperm motility.弱精症的蛋白质组学分析及鉴定葡萄糖-6-磷酸异构酶为精子运动的重要酶。
J Proteomics. 2019 Sep 30;208:103478. doi: 10.1016/j.jprot.2019.103478. Epub 2019 Aug 5.
7
Proteomic profile of human spermatozoa in healthy and asthenozoospermic individuals.健康男性和弱精症患者精子的蛋白质组学特征。
Reprod Biol Endocrinol. 2018 Feb 27;16(1):16. doi: 10.1186/s12958-018-0334-1.
8
Promoter targeted bisulfite sequencing reveals DNA methylation profiles associated with low sperm motility in asthenozoospermia.启动子靶向亚硫酸氢盐测序揭示了与弱精子症中精子活力低下相关的DNA甲基化谱。
Hum Reprod. 2016 Jan;31(1):24-33. doi: 10.1093/humrep/dev283. Epub 2015 Nov 30.
9
RNASET2 in human spermatozoa and seminal plasma: a novel relevant indicator for asthenozoospermia.人精子和精浆中的 RNASET2:弱精子症的一个新的相关指标。
Andrology. 2013 Jan;1(1):75-84. doi: 10.1111/j.2047-2927.2012.00022.x. Epub 2012 Oct 9.
10
RNASET2 impairs the sperm motility via PKA/PI3K/calcium signal pathways.RNASET2 通过 PKA/PI3K/钙信号通路损害精子活力。
Reproduction. 2018 Apr;155(4):383-392. doi: 10.1530/REP-17-0746.

引用本文的文献

1
Blood plasma trimethylamine N-oxide and related metabolites and asthenozoospermia odds: a hospital-based matched case-control study in China.血浆三甲胺 N-氧化物及相关代谢物与弱精子症几率:一项基于中国医院的配对病例对照研究。
Hum Reprod Open. 2025 Aug 18;2025(3):hoaf045. doi: 10.1093/hropen/hoaf045. eCollection 2025.
2
Biallelic loss-of-function variants of DNAH7 cause male infertility associated with asthenozoospermia in humans.DNAH7的双等位基因功能丧失变异导致人类与弱精子症相关的男性不育。
Hum Genet. 2025 Aug 14. doi: 10.1007/s00439-025-02766-6.
3
Combining photobiomodulation and naringenin for treatment of asthenozoospermia: A promising therapeutic approach.
联合光生物调节和柚皮素治疗弱精子症:一种有前景的治疗方法。
Lasers Med Sci. 2025 Aug 6;40(1):330. doi: 10.1007/s10103-025-04563-z.
4
Bridging the gap: how sperm's core structure explains male infertility.弥合差距:精子的核心结构如何解释男性不育症。
Cell Res. 2025 Jul 15. doi: 10.1038/s41422-025-01150-3.
5
Sphingolipids and Male Reproductive Health: A Narrative Review of Their Roles in Spermatogenesis, Fertility, and Dysfunction.鞘脂与男性生殖健康:关于其在精子发生、生育能力及功能障碍中作用的叙述性综述
Reprod Sci. 2025 Jun 12. doi: 10.1007/s43032-025-01898-4.
6
Acupuncture mediates the "gut-testis axis" to improve asthenozoospermia.针灸通过调节“肠-睾丸轴”来改善弱精子症。
Front Endocrinol (Lausanne). 2025 Jan 27;16:1514010. doi: 10.3389/fendo.2025.1514010. eCollection 2025.
7
The effects of L-carnitine and fructose in improved Ham's F10 on sperm culture in idiopathic severe asthenospermia within 24h.左旋肉碱和果糖对改良哈姆氏F10培养基培养特发性严重弱精子症患者精子24小时内效果的影响。
PLoS One. 2025 Feb 10;20(2):e0306235. doi: 10.1371/journal.pone.0306235. eCollection 2025.
8
Platelet Mitochondrial Function and Endogenous Coenzyme Q Levels Could Be Used as Markers of Mitochondrial Health in Infertile Men: A Pilot Study.血小板线粒体功能和内源性辅酶Q水平可用作不育男性线粒体健康的标志物:一项初步研究。
Int J Mol Sci. 2024 Dec 31;26(1):268. doi: 10.3390/ijms26010268.
9
Human asthenozoospermia: Update on genetic causes, patient management, and clinical strategies.人类弱精子症:遗传病因、患者管理及临床策略的最新进展
Andrology. 2025 Jul;13(5):1044-1064. doi: 10.1111/andr.13828. Epub 2025 Jan 2.
10
Umbilical Cord-Derived Mesenchymal Stem Cells Improve Ornidazole-Induced Asthenozoospermia in Rats via Activation of the AKT/mTOR Pathway.脐带间充质干细胞通过激活AKT/mTOR信号通路改善奥硝唑诱导的大鼠弱精子症
Int J Endocrinol. 2024 Nov 12;2024:3494652. doi: 10.1155/2024/3494652. eCollection 2024.